Pharma watch out: St Jude aims for renal denervation EnligHTNment
This article was originally published in Clinica
Executive Summary
St Jude Medical has started a trial of its EnligHTN renal denervation device that could broaden the patient population eligible for treatment and also reduce the use of antihypertensive drugs by up to 30%. That is according to Professor Michael Böhm, one of the lead investigators of the new trial, called EnligHTNment.